IVF and Ovarian Reserve Testing: AMH, AFC Explained

Ovarian reserve testing is the clinical foundation on which IVF treatment planning is built. Before a fertility specialist can design your stimulation protocol, predict your likely response, set realistic expectations for egg numbers, and make decisions about adjuvant medications, they need accurate information about how many follicles remain in your ovaries and how they are likely to respond to stimulation. The two most clinically informative measures of this ovarian reserve are AMH, the blood-based anti-Müllerian hormone test, and AFC, the antral follicle count performed by transvaginal ultrasound.

These two tests complement each other in ways that provide a more complete picture together than either provides alone, and understanding what each measures, how it is performed, what its specific strengths and limitations are, and how to interpret your results in the context of your individual clinical situation gives you the knowledge to engage meaningfully with one of the most important pieces of information in your IVF preparation.

What AMH Is and What It Measures

Anti-Müllerian hormone is a glycoprotein produced by the granulosa cells that surround the small antral follicles in the ovaries. Its production is proportional to the number of small antral follicles present in the ovaries, meaning that higher AMH levels indicate a larger pool of these follicles and therefore greater ovarian reserve. Lower AMH levels indicate a smaller follicle pool and reduced ovarian reserve.

The biological rationale for using AMH as an ovarian reserve marker is that AMH production occurs in the earliest stages of follicular development and is relatively constant throughout the menstrual cycle. Unlike FSH and LH, which fluctuate significantly across the cycle in response to the feedback signals of dominant follicle development and ovulation, AMH reflects the resting follicle pool rather than the active hormonal dynamics of any particular cycle phase. This cycle-independence makes AMH measurable on any day without requiring cycle-day-specific timing.

AMH is produced from the transition from primordial to primary follicle and continues through the preantral and small antral stages. As follicles grow larger they lose AMH expression, meaning that large growing follicles do not contribute to the AMH measurement. The AMH level therefore specifically reflects the pool of small follicles that are available for stimulation in any given IVF cycle, making it the most direct blood-based measure of stimulable ovarian reserve.

Interpreting AMH Results

AMH results are reported in either nanograms per millilitre or picomoles per litre depending on the laboratory, and the units are not interchangeable. Confirming which unit your result is expressed in before comparing it against reference ranges is important to avoid misinterpretation.

Reference ranges for AMH vary between laboratories and between the clinical guidelines of different reproductive medicine organisations. The ranges below represent commonly used clinical thresholds that should be interpreted in conjunction with age and clinical context rather than applied rigidly.

AMH above 4.0 ng/mL in women under 35 is generally associated with a high ovarian reserve and a potential risk of excessive response to standard stimulation doses. In the context of IVF this means conservative protocol design to minimise OHSS risk.

AMH between 1.0 and 4.0 ng/mL represents a normal range associated with a good predicted response to standard stimulation in most women under 40.

AMH between 0.5 and 1.0 ng/mL indicates a reduced but not severely diminished reserve. Expected egg numbers per stimulation cycle are lower than average but remain clinically workable in most cases.

AMH below 0.5 ng/mL indicates diminished ovarian reserve where stimulation response is expected to be limited. Protocol optimisation, realistic expectation-setting, and potentially multiple cycles to accumulate adequate embryos are considerations at this level.

AMH below 0.1 ng/mL represents severely diminished ovarian reserve where minimal or no response to stimulation is possible. At this level the conversation about donor eggs becomes clinically relevant, though individual results can be surprising and natural cycle IVF or low stimulation approaches may still be considered.

The critical clinical context for interpreting any AMH result is age. A thirty-two-year-old with AMH of 0.8 ng/mL has a fundamentally different prognosis from a forty-two-year-old with the same AMH level, because the egg quality advantage of the younger patient’s age substantially improves the probability that the limited eggs she produces will be chromosomally normal and capable of resulting in successful pregnancy.

What the Antral Follicle Count Measures

The antral follicle count is performed by transvaginal ultrasound, typically on cycle day two or three of a natural cycle before stimulation begins, and involves counting the number of small resting follicles visible in both ovaries combined. These antral follicles, measuring two to ten millimetres in diameter, represent the cohort of follicles at the stage of development most directly responsive to FSH stimulation and therefore the most direct ultrasound-based measure of how many follicles can potentially be recruited in an IVF stimulation cycle.

The AFC and AMH measure closely related aspects of the ovarian reserve. Both reflect the population of small antral follicles, and they correlate strongly in most patients because AMH production comes from the same follicle population that constitutes the antral follicle count. However, the correlation is not perfect, and there are clinically informative situations in which AMH and AFC diverge.

A patient with a very high AMH but a surprisingly low AFC on a given cycle day may have had her antral follicle assessment conducted at a suboptimal phase of the cycle, or may have a higher proportion of very small follicles below the sonographic detection threshold that contribute to AMH but are not visible on ultrasound. Repeat AFC assessment or comparison against the AMH result helps resolve these discrepancies.

A patient with a low AMH but a higher AFC than expected may have follicles whose granulosa cells produce less AMH per follicle than average, which has been associated with poorer per-egg quality in some research even when follicle numbers appear adequate.

How AFC Is Performed and What Affects Its Accuracy

AFC accuracy depends significantly on the experience of the sonographer performing the measurement, the quality of the ultrasound equipment, and the timing of the assessment within the menstrual cycle.

Experienced sonographers using high-resolution equipment with good pelvic visibility through an adequately distended bladder achieve more reproducible and more accurate antral follicle counts than less experienced operators or those working with lower-resolution equipment. The specific technique used, including the plane of measurement and the size cutoffs applied for inclusion as antral follicle versus dominant follicle, varies between operators and between clinics and represents a source of inter-operator variability that should be acknowledged when comparing AFC results between different assessors.

Cycle day timing affects AFC because the follicle population visible on day two or three of a cycle differs from that visible on day ten as dominant follicle development begins to change the ovarian appearance. Cycle day two or three assessment before significant follicular growth has begun provides the most standardised and most reproducible AFC measurement.

Oral contraceptive pill use suppresses the hypothalamic-pituitary-ovarian axis and reduces AFC to a degree during active pill use. AFC assessed during or immediately after pill use may underestimate true ovarian reserve and should ideally be obtained after an interval without hormonal contraception.

AMH and AFC Together: The Complete Reserve Picture

The combination of AMH and AFC provides the most reliable pre-IVF ovarian reserve assessment available. When both measures point in the same direction, the combined assessment provides stronger clinical confidence in the predicted response. When they diverge, the discrepancy itself is clinically informative and warrants further assessment or at minimum careful protocol design that accounts for the uncertainty.

Adding FSH and estradiol on cycle day two or three completes the standard hormonal reserve assessment, as FSH provides a functional pituitary perspective on the follicle pool and estradiol validates the FSH measurement by excluding suppression artefacts.

What Reserve Testing Cannot Tell You

The most important limitation of ovarian reserve testing to communicate clearly is that it predicts ovarian response to stimulation and egg quantity but does not directly measure egg quality. This distinction is critical for patient communication because the emotional response to a low AMH result often reflects a misunderstanding that low reserve means low-quality eggs.

AMH and AFC tell you approximately how many eggs are available. Age is the primary determinant of the quality of those eggs. A younger woman with low AMH has fewer eggs available but those eggs are predominantly of good quality. An older woman with normal AMH has more eggs available but a higher proportion are chromosomally abnormal. The combination of both age and reserve determines the overall clinical picture.

Connecting with an experienced Best IVF Center in Sikar that conducts thorough ovarian reserve assessment combining AMH with expert AFC assessment, communicates results clearly with age-appropriate context, and translates reserve testing into individualised protocol recommendations ensures that your ovarian reserve assessment genuinely informs your treatment plan rather than serving only as a number on a report.

Final Thoughts

AMH and AFC are the most informative tests available for predicting IVF stimulation response, but their interpretation requires clinical context, age-specific reference, and integration with the complete clinical picture of both partners. A number in isolation is rarely as informative or as alarming as it initially appears. A number interpreted by a clinician who understands your complete fertility profile is the foundation of a realistic and well-designed treatment plan.

For expert ovarian reserve assessment, accurate AFC measurement, and individualised treatment planning that translates reserve testing into the most appropriately designed stimulation protocol for your specific profile, a trusted ivf clinic in jaipur with experienced sonographers and reproductive endocrinologists who integrate reserve testing meaningfully into clinical decision-making gives your IVF preparation the most evidence-based and most personally relevant foundation available.

Disclaimer: This article is intended for informational purposes only and does not constitute medical advice. Please consult a qualified fertility specialist for guidance tailored to your individual health and treatment needs.